The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes
NCT ID: NCT01067482
Last Updated: 2010-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2009-09-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advanced Glaucoma Progression Study
NCT01742819
Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia
NCT05964634
Spectral Domain Optical Coherence Tomography Analysis for Glaucoma
NCT01612416
OCTA in Patients With Primary Open-angle Glaucoma
NCT06214676
Functional and Structural Imaging for Glaucoma
NCT01957267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glaucoma patients
No interventions assigned to this group
Glaucoma suspect group
No interventions assigned to this group
Normal population
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* refractive error +/- 5 D Or astig +/- 3 D
* enrolled in 3 population group (glaucoma, glaucoma suspect or normal)
Exclusion Criteria
* marked RF error
* previous ocular trauma or surgery
* unreliable visual field
* poor signal cirrus OCT (less than 7)
* other causes of optic nerve or macular disease other than glaucoma
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prince of Songkla University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University Hat-yai,, Songkhla, Thailand., Thailand
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weerawat Kiddee, MD
Role: PRINCIPAL_INVESTIGATOR
Prince of Songkla University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University
Hat Yai, Songkhla, Thailand., Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC 52-336-02-1-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.